A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder
Clinical trial NCT00796081 · COMPLETED
Trial details
- NCT number
- NCT00796081
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.